Additional Portfolio Brings Relationship to 3.7GW of Investment in U.S. Generation ENGIE North America (ENGIE) announced that it recently expanded its partnership with Ares Management Infrastructure Opportunities funds (Ares) via the addition of a new almost 1 GW portfolio. ENGIE will retain a controlling share in the portfolio and will continue to operate and manage […]

(NASDAQ:WINT), WARRINGTON, Pa., March 24, 2025 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating biotech and advancing early and late-stage innovative therapies for critical conditions and diseases, today announced that the Company received notice from The Nasdaq Stock Market LLC (“Nasdaq”) that

(NasdaqGM:KBSX), Boulder, CO, March 24, 2025 (GLOBE NEWSWIRE) — FST Corp. (Nasdaq: KBSX), a leading manufacturer and marketer of steel and graphite golf shafts and a provider of other golf-related services, today announced the launch of a graphite shaft engineered to produce greater distance and enhanced accuracy in fairway woods, the type of golf club

(NASDAQ:OXBR),(NASDAQ:OXBRW), GRAND CAYMAN, Cayman Islands, March 24, 2025 (GLOBE NEWSWIRE) — Oxbridge Re Holdings Limited (Nasdaq: OXBR) (“Oxbridge Re”), together with its subsidiary SurancePlus, is engaged in the tokenization of Real-World Assets (“RWAs”), initially with tokenized reinsurance securities and in providing reinsurance solutions to property and casualty insurers in the Gulf Coast region of the

(PinkSheets:XONI),(Pinksheets:XONI), MAIN EVENT: Kenny “The Boss” Cross vs. Lucas “Lubera” CorbageCO-MAIN EVENT: Alex Nicholson vs. Darion AbbeySPECIAL ATTRACTION: Victor Moreno vs. Thiago OliveiraALSO: Marcos Brigagao vs. Emiliano SordiSaidyokub Kakhramonov vs. Bruno SantosJaron Lathrop vs. Yevgeni Shinkarevsky MIAMI, March 24, 2025 (GLOBE NEWSWIRE) — Xtreme One Entertainment, Inc. (OTC: XONI) and beIN SPORTS today announced the

(NASDAQ:TNXP), On track for August 15, 2025 FDA PDUFA goal date TNX-102 SL is a non-opioid analgesic; if approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years Commercial planning for TNX-102 SL underway for launch in the fourth quarter of 2025 CHATHAM, N.J., March 24, 2025 (GLOBE

(NASDAQ:SLRX), Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate clinical development of novel peptide conjugate therapeutics for treating respiratory viruses and cancer Updates expected later this year from the MD Anderson Cancer Center (MDACC) investigator-initiated Phase 1/2 clinical trial of seclidemstat in combination with azacitidine to treat hematologic

(NYSE:HII), MCLEAN, Va., March 24, 2025 (GLOBE NEWSWIRE) — HII (NYSE: HII) announced today that its Mission Technologies division was selected to develop an open architecture High-Energy Laser (HEL) weapon system for the U.S. Army's Rapid Capabilities and Critical Technologies Office (RCCTO). HII will develop and test a HEL prototype to acquire, track and destroy

ANN ARBOR, Mich., March 24, 2025 (GLOBE NEWSWIRE) — A national technology competition seeks innovative solutions for maintenance and sustainment operations, sponsored annually by the National Center for Manufacturing Sciences (NCMS) to provide the Department of Defense (DOD) with new ways to improve operations. The 2025 Commercial Technologies for Maintenance Activities (CTMA) Technology Competition highlights

— Robert brings nearly 30 years of commercial real estate experience along with deep corporate relationships acrossEMEA, Asia and North America. Blue Owl Capital Inc. (“Blue Owl”) (NYSE: OWL), a leading alternative asset manager, announced today the hiring of Robert Campkin as part of the Company's European Net Lease Strategy. Robert will join as a